E

Evotec SE
XETRA:EVT

Watchlist Manager
Evotec SE
XETRA:EVT
Watchlist
Price: 9.215 EUR 1.99%
Market Cap: 1.6B EUR
Have any thoughts about
Evotec SE?
Write Note

Operating Margin
Evotec SE

-12.1%
Current
-0.5%
Average
2.4%
Industry

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
-12.1%
=
Operating Profit
-93.6m
/
Revenue
777.1m

Operating Margin Across Competitors

Country DE
Market Cap 1.6B EUR
Operating Margin
-12%
Country US
Market Cap 1.3T USD
Operating Margin
14%
Country US
Market Cap 196.2B USD
Operating Margin
17%
Country US
Market Cap 170.9B USD
Operating Margin
21%
Country KR
Market Cap 67.6T KRW
Operating Margin
31%
Country CH
Market Cap 38.5B CHF
Operating Margin
13%
Country US
Market Cap 38.6B USD
Operating Margin
25%
Country US
Market Cap 36.5B USD
Operating Margin
14%
Country US
Market Cap 26.7B USD
Operating Margin
28%
Country US
Market Cap 23.2B USD
Operating Margin
20%
Country US
Market Cap 23B USD
Operating Margin
29%
No Stocks Found

Evotec SE
Glance View

Market Cap
1.6B EUR
Industry
Life Sciences Tools & Services

Evotec SE engages in the discovery and development of new drugs for pharmaceutical and biotechnology companies. The company is headquartered in Hamburg, Hamburg and currently employs 4,521 full-time employees. The firm is engaged in development of new pharmaceutical products through research alliances and development partnerships with pharmaceutical and biotechnology companies, academic institutions, patient organizations and venture capital companies. The drug discovery solutions are provided in the form of fee-for-service work, integrated drug discovery alliances, development partnerships, licensing of drug candidates and consulting arrangements. Evotec SE operates in a number of areas, including neuroscience, diabetes and complications of diabetes, pain and inflammation, oncology, infectious diseases, respiratory diseases and fibrosis. Its pipeline covers a range of therapeutic areas, such as CNS Insomnia, Chronic cough, immunology & inflammation, women’s health endometriosis, nephrology, dermatological diseases, fibrotic disease and antiviral, among others.

EVT Intrinsic Value
12.726 EUR
Undervaluation 28%
Intrinsic Value
Price
E

See Also

Discover More
What is Operating Margin?

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
-12.1%
=
Operating Profit
-93.6m
/
Revenue
777.1m
What is the Operating Margin of Evotec SE?

Based on Evotec SE's most recent financial statements, the company has Operating Margin of -12.1%.